WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved PCORI investing up to $600 million in patient-centered comparative clinical effectiveness research (CER) through the development…

In response to the increasing crises of over 700 maternal deaths and nearly 73,000 reported cases of maternal morbidity occurring in the United States as recently as 2022, maternal morbidity…

WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) today began inviting proposals for new studies and implementation projects through nine funding opportunities. These PCORI Funding Announcements (PFAs) include four…

WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) today announced funding awards totaling $123 million to support 15 new research studies. These studies aim to fill evidence gaps, enhance…

WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) has opened the application periods for nine funding opportunities that offer up to $308.5 million in total funding. The latest PCORI…

WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) today announced funding awards totaling $96 million to support 18 new research studies. These studies aim to fill evidence gaps and…

Editor's Note (February 27, 2023) These eight Topic Themes join four that are ongoing—preventing maternal morbidity and mortality, improving outcomes for people with intellectual or developmental disabilities, addressing COVID-19, and…

WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) has approved funding awards totaling $258 million to support 26 new research studies. These studies aim to fill evidence gaps and…

On May 3, PCORI opened its second funding cycle of the year and started accepting Letters of Intent for several PCORI Funding Announcements (PFAs), which include calls for: Research studies…

WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) today began accepting proposals for new studies and implementation projects through seven funding opportunities. These PCORI Funding Announcements (PFAs) include a…

Each week throughout April, in recognition of National Minority Health Month, PCORI will spotlight health conditions that disproportionately affect communities of color. One of PCORI's National Priorities for Health is…

Each week throughout April, in recognition of National Minority Health Month, PCORI will spotlight health conditions that disproportionately affect communities of color. One of PCORI's National Priorities for Health is…

WASHINGTON, DC—The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved several slates of funding awards totaling about $71.5 million to support 12 new comparative clinical effectiveness research (CER)…

Heart disease is widespread and sadly, often deadly. According to the Centers for Disease Control and Prevention, heart disease is the leading cause of death in the United States. While…

People with cardiovascular disease (CVD) taking aspirin to lower their chances of suffering a heart attack or stroke experienced similar health benefits, including reduced death and hospitalization for heart attack and stroke, whether they took a high or low dose of aspirin, according to a study presented today at ACC.21, the American College of Cardiology’s 70th Annual Scientific Session and published in the New England Journal of Medicine.

More than a dozen topics ranging from healthy aging to prevention of drug addiction among adolescents and from telehealth to addressing bias, racism and discrimination throughout the health care continuum will be the focus of efforts to develop future research funding opportunities from the Patient-Centered Outcomes Research Institute (PCORI) following approval at today’s PCORI Board of Governors meeting.

The American Heart Association and PCORI are excited to announce a major step in a multiyear partnership to identify and fund cardiovascular health research that will make a difference in…

A new research center will produce and test decision aids to help people with atrial fibrillation (AFib) more readily make choices with their doctors about their treatment options, thanks to a $5 million funding award. The Patient-Centered Outcomes Research Institute (PCORI) and American Heart Association (AHA) announced the selection of the research team and home for the center today.

Despite decades of progress in research and delivery of care, cardiovascular diseases continue to impose a heavy burden on our nation, even though the disease is manifesting later in life…

Building on our hallmark of engaging healthcare stakeholders in all phases of research, PCORI is excited to join the American Heart Association (AHA) in announcing a crowdsourcing challenge for clinicians…

Native Americans have the highest rate of diabetes of all US racial and ethnic groups. Around 16 percent of American Indian and Alaska Native adults have been diagnosed with that…

Over-the-counter aspirin is as effective as low-molecular-weight heparin, a commonly used injectable blood thinner, in preventing life-threatening blood clots among patients hospitalized due to a fracture, according to findings from…

Cardiovascular disease is the number one cause of death for older adults and disproportionately affects Black and Hispanic communities. In a recent article published in The Washington Post, produced by…

The latest Emerging Health Care Innovation Brief highlights doxycycline, an oral antibiotic for sexually transmitted bacterial infections like chlamydia, gonorrhea, and syphilis, which can be difficult to treat, and might…

Kawasaki disease is a rare form of cardiovascular disease that mainly affects children. The condition causes widespread inflammation and can lead to focal swelling, or aneurysm formation, of the arteries…